BFA
KERX

BlackRock Fund Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

BlackRock Fund Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13.9M Buy
2,372,234
+350,552
+17% +$1.92M ﹤0.01% 2388
2016
Q3 		$10.7M Buy
2,021,682
+136,834
+7% +$738K ﹤0.01% 2425
2016
Q2 		$12.5M Sell
1,884,848
-596,985
-24% -$3.34M ﹤0.01% 2282
2016
Q1 		$11.6M Sell
2,481,833
-87,705
-3% -$350K ﹤0.01% 2279
2015
Q4 		$13M Buy
2,569,538
+109,250
+4% +$519K ﹤0.01% 2299
2015
Q3 		$8.66M Sell
2,460,288
-24,241
-1% -$162K ﹤0.01% 2466
2015
Q2 		$24.8M Sell
2,484,529
-125,111
-5% -$1.34M 0.01% 1978
2015
Q1 		$33.2M Buy
2,609,640
+275,752
+12% +$3.54M 0.01% 1780
2014
Q4 		$33M Buy
2,333,888
+346,328
+17% +$5.37M 0.01% 1757
2014
Q3 		$27.3M Sell
1,987,560
-59,814
-3% -$916K 0.01% 1766
2014
Q2 		$31.5M Sell
2,047,374
-454,367
-18% -$6.44M 0.01% 1724
2014
Q1 		$42.6M Buy
2,501,741
+280,436
+13% +$4.23M 0.01% 1526
2013
Q4 		$28.8M Sell
2,221,305
-87,431
-4% -$1.04M 0.01% 1768
2013
Q3 		$23.3M Buy
2,308,736
+270,384
+13% +$2.41M 0.01% 1867
2013
Q2 		$15.2M Buy
+2,038,352
New +$15.9M 0.01% 2009

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

BlackRock Fund Advisors's KERX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Keryx Biopharmaceuticals Inc (KERX) stake by 17% in Q4 2016, buying an estimated $1.92M and bringing the position to 2,372,234 shares worth $13.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

BlackRock Fund Advisors first reported a position in KERX in Q2 2013 and has held it in 15 quarters since. The position peaked at $42.6M in Q1 2014. 123 funds tracked by Wall St. Rank hold KERX as of Q4 2016.

  • BlackRock Fund Advisors held 2,372,234 shares of Keryx Biopharmaceuticals Inc worth $13.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 350,552 Keryx Biopharmaceuticals Inc shares in Q4 2016, an estimated $1.92M.
  • Keryx Biopharmaceuticals Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2388 holding.
  • BlackRock Fund Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Keryx Biopharmaceuticals Inc position peaked at $42.6M in Q1 2014.
  • 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.